← All Sponsors
SPONSOR

Onconic Therapeutics Inc.

Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 3
Conditions studied: Drug Drug Interaction (DDI)Peptic Ulcer
NCT07265466 Phase 1
Recruiting

to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban

Drug Drug Interaction (DDI)
South Korea View Trial →
NCT06439563 Phase 3
Recruiting

Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers

Peptic Ulcer
South Korea View Trial →